Emergent Biosolutions Inc (EBS): Next-Year EPS Estimate 190.99%
As of 2026-10-10, Emergent Biosolutions Inc (EBS) has a next-year EPS growth estimate of 190.99%. Featured in 3 EPS revision reports, most recently on 2026-08-29.
On 2026-08-21, analyst consensus for EBS's next-year EPS growth shifted from 2933.33% to 190.99% — a negative change of 2742.34 percentage points. The revised estimate has been sustained across 46 subsequent trading sessions. Current-year growth is projected at -76.50%.
What's Driving This
The only quantified analyst revision around Emergent BioSolutions was a
Generated 2026-09-16 from news as of 2026-09-16
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 190.99%
- EPS growth this year
- -76.50%
- EPS next quarter (est)
- -$0.39
- Last price
- $7.06
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-10-10 | 190.99% | -76.50% | -$0.39 | $7.06 |
| 2026-10-09 | 190.99% | -76.50% | -$0.39 | $7.06 |
| 2026-10-08 | 190.99% | -76.50% | -$0.39 | $6.81 |
| 2026-10-07 | 190.99% | -76.50% | -$0.39 | $7.07 |
| 2026-10-06 | 190.99% | -76.50% | -$0.39 | $6.95 |
| 2026-10-05 | 190.99% | -76.50% | -$0.39 | $7.24 |
| 2026-10-04 | 190.99% | -76.50% | -$0.39 | $6.33 |
| 2026-10-03 | 190.99% | -76.50% | -$0.39 | $6.33 |
| 2026-10-02 | 190.99% | -76.50% | -$0.39 | $6.33 |
| 2026-10-01 | 190.99% | -76.50% | -$0.39 | $6.37 |
| 2026-09-30 | 190.99% | -76.50% | -$0.39 | $6.60 |
| 2026-09-29 | 190.99% | -76.50% | -$0.39 | $6.92 |
| 2026-09-28 | 190.99% | -76.50% | -$0.39 | $6.86 |
| 2026-09-27 | 190.99% | -76.50% | -$0.39 | $6.79 |
| 2026-09-25 | 190.99% | -76.50% | -$0.39 | $6.79 |
| 2026-09-24 | 190.99% | -76.50% | -$0.39 | $6.77 |
| 2026-09-23 | 190.99% | -76.50% | -$0.39 | $6.67 |
| 2026-09-22 | 190.99% | -76.50% | -$0.39 | $6.76 |
| 2026-09-21 | 190.99% | -76.50% | -$0.39 | $6.55 |
| 2026-09-20 | 190.99% | -76.50% | -$0.39 | $6.80 |
| 2026-09-18 | 190.99% | -76.50% | -$0.39 | $6.80 |
| 2026-09-17 | 190.99% | -76.50% | -$0.39 | $7.02 |
| 2026-09-16 | 190.99% | -76.50% | -$0.39 | $6.75 |
| 2026-09-15 | 190.99% | -76.50% | -$0.39 | $6.36 |
| 2026-09-14 | 190.99% | -76.50% | -$0.39 | $6.38 |
| 2026-09-13 | 190.99% | -76.50% | -$0.39 | $6.23 |
| 2026-09-11 | 190.99% | -76.50% | -$0.39 | $6.23 |
| 2026-09-10 | 190.99% | -76.50% | -$0.39 | $5.87 |
| 2026-09-09 | 190.99% | -76.50% | -$0.39 | $5.68 |
| 2026-09-08 | 190.99% | -76.50% | -$0.39 | $6.00 |
Reports Featuring EBS
Recent News
- Emergent BioSolutions Inc. Q1 2026 Earnings Call SummaryMoby
- Emergent BioSolutions Inc (EBS) Q1 2026 Earnings Call Highlights: Strong Revenue and Strategic ...GuruFocus.com
- Emergent Biosolutions: Q1 Earnings SnapshotAssociated Press
- Emergent BioSolutions Reports First Quarter 2026 Financial ResultsGlobeNewswire
Screen Performance
Aggregate stats across all 2077 tickers our top-EPS-revision screen has flagged over the past 192 days.
- Median return since detection
- -0.9%
- % of tickers in the green
- 47%
- Median return on winners
- +23.2%
- Large revisions captured
- 1848
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Emergent Biosolutions Inc's next-year EPS growth estimate?▾
As of 2026-10-10, Emergent Biosolutions Inc (EBS) has a next-year EPS growth estimate of 190.99%, based on analyst consensus.
When was the latest EPS estimate revision for EBS?▾
The most recent revision occurred on 2026-08-21, when analysts adjusted the next-year EPS growth estimate from 2933.33% to 190.99%.
What sector and industry does Emergent Biosolutions Inc belong to?▾
Emergent Biosolutions Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. EBS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Emergent Biosolutions Inc (EBS) appears here because it was detected by our daily top-EPS-revision-performer screen.